Talc and Ovarian Cancer Lawsuits: Unraveling the Controversy


Talc, a mineral widely used in various consumer products, has found itself at the center of a growing controversy in recent years. This controversy stems from the alleged link between talc-based products, such as talcum powder, and an increased risk of ovarian cancer in women. 

The resulting wave of lawsuits against talc manufacturers has raised questions about product safety, corporate responsibility, and the legal landscape surrounding these cases.

Understanding Talc and its Uses

Talc, composed of magnesium, silicon, and oxygen, is a naturally occurring mineral that has been mined for centuries. Known for its softness and moisture-absorbing properties, talc has been a common ingredient in cosmetic and personal care products. 

Talcum powder, made from finely ground talc, gained popularity for its use in personal hygiene routines, particularly for babies and women.

Talcum Powder and Ovarian Cancer Allegations

The controversy surrounding talcum powder and ovarian cancer first gained significant attention in the early 2000s. Some studies suggested that the use of talcum powder in the genital area could increase the risk of ovarian cancer. 

The concern was based on the idea that talc particles could travel through the reproductive system and reach the ovaries, leading to inflammation and the development of cancerous cells.

While research results have been mixed, with some studies finding a correlation and others not, the issue prompted many women who had been diagnosed with ovarian cancer to question whether their use of talcum powder played a role in their illness. This led to a surge in lawsuits against companies producing talc-based products.

Landmark Cases and Legal Developments

One of the most notable cases that brought the talc ovarian cancer link into the spotlight was the 2013 lawsuit involving Johnson & Johnson (J&J), a leading consumer health company. 

In this case, a woman named Deane Berg claimed that her long-term use of J&J’s talcum powder products had contributed to her ovarian cancer diagnosis.

The jury in Berg’s case did not award damages to the plaintiff, but it opened the floodgates for subsequent lawsuits against J&J and other talc manufacturers. 

Over the following years, numerous trials took place, with some resulting in substantial verdicts against the companies. 

These verdicts were based on allegations that the manufacturers were aware of potential risks associated with talc use but failed to adequately warn consumers.

In 2018, a Missouri jury awarded $4.69 billion in damages to 22 women who claimed that long-term use of J&J’s talcum powder products contributed to their ovarian cancer. 

This decision marked one of the largest verdicts in the talc ovarian cancer lawsuits. However, J&J has consistently denied any wrongdoing and has appealed many of these verdicts.

Scientific Controversy and Regulatory Response

The scientific community has been divided on the link between talcum powder and ovarian cancer. Some studies have suggested an increased risk, while others have found no conclusive evidence. 

The International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), classified talc-based body powder as “possibly carcinogenic to humans” when used in the genital area.

However, the U.S. Food and Drug Administration (FDA) has taken a more cautious but neutral stance. 

As of my last knowledge update in January 2022, the FDA’s website stated that it had not found conclusive evidence to establish a causal relationship between talc use and ovarian cancer. The agency continues to monitor the scientific literature and evaluate new evidence.

The talc industry, including companies like J&J, has consistently defended the safety of their products, emphasizing that the majority of scientific studies do not support a causal link between talc and ovarian cancer. 

They argue that talc is one of the most widely studied minerals and has been used safely for decades.

Legal Challenges and Industry Response

The talc lawsuits have presented significant challenges for the companies involved. Apart from the financial implications of multi-million-dollar verdicts, these cases have also damaged the reputation of some well-established brands. 

Johnson & Johnson, in particular, faced a public relations crisis as media coverage highlighted internal documents suggesting the company was aware of potential asbestos contamination in its talc products.

In response to the legal challenges and public concerns, some talc manufacturers have taken steps to address the issue. J&J, for example, has reformulated its iconic baby powder to be talc-free and has emphasized the safety of its cornstarch-based products. 

Additionally, the company announced in 2020 that it would stop selling talc-based baby powder in the United States and Canada, citing declining consumer demand and misinformation about the product’s safety.

The talc industry has also become more transparent about testing and quality control measures to ensure the absence of asbestos, a known carcinogen, in their talc products.

Asbestos contamination in talc has been a separate but related concern, as asbestos exposure is definitively linked to various forms of cancer, including mesothelioma.

Implications for Consumers and Public Health

The talc ovarian cancer lawsuit has far-reaching implications for consumers and public health. 

The controversy has heightened awareness about the potential risks associated with everyday products, prompting individuals to scrutinize the ingredients in personal care items more closely. 

This increased awareness has also led to a growing demand for safer and more transparent formulations in cosmetic and personal care products.

Consumers are encouraged to make informed choices, understanding the ingredients in the products they use and staying informed about any potential health risks. 

This shift in consumer behavior has prompted some companies to adopt more rigorous testing and transparency in disclosing product ingredients and manufacturing processes.

However, the lack of conclusive scientific evidence linking talc to ovarian cancer makes it challenging to establish clear guidelines for consumers. 

The conflicting findings in various studies underscore the need for continued research to determine the potential risks associated with talc use, especially in intimate areas.


The talc ovarian cancer lawsuits have brought to light a complex and controversial intersection of science, law, and public health. 

While some women have received substantial compensation for their alleged injuries, the overall scientific consensus on the talc-ovarian cancer link remains elusive. 

The legal battles have underscored the challenges of navigating the intersection between scientific evidence, legal liability, and corporate responsibility.

As the controversy continues, it is essential for the scientific community to conduct further research to establish a clearer understanding of the potential risks associated with talc use. At the same time, the legal system must grapple with the complexities of these cases, ensuring a fair and just resolution for those affected. In the broader context, the talc ovarian cancer lawsuits have triggered a shift in consumer behavior and industry practices, emphasizing the importance of transparency, safety, and accountability in the manufacturing of personal care products.